logo

Durect Corp. (DRRX)



Trade DRRX now with
  Date
  Headline
5/26/2020 8:33:17 AM DURECT Announces Positive Topline Data From Phase 1b Study Of DUR-928 In NASH
1/17/2020 6:50:38 AM DURECT Says FDA Committee Voted 6-6 On Safety And Efficacy Of POSIMIR
1/16/2020 7:08:02 AM DURECT Trading Halted Today; FDA Advisory Committee To Discuss POSIMIR For Post-Surgical Analgesia
1/2/2020 9:02:52 AM DURECT Reports Results From Phase 2a Clinical Trial Of DUR-928 In Patients With Mild To Moderate Plaque Psoriasis
11/12/2019 8:50:47 AM DURECT Announces Positive Results From Phase 2a Trial Of DUR-928 In Alcoholic Hepatitis Patients
10/7/2019 8:03:53 AM DURECT Closes Enrollment In Phase2a Trial Of DUR-928 In Psoriasis And 50% Enrollment In Phase 1b DUR-928 Trial In NASH
10/2/2019 8:05:59 AM DURECT Reports FDA Advisory Committee Meeting To Review POSIMIR For Treatment Of Post-Surgical Pain
9/23/2019 5:50:04 AM What Awaits DURECT In Q4?
9/17/2019 8:01:51 AM DURECT Announces Positive Data From Its Phase 2a Clinical Trial Of DUR-928 In Alcoholic Hepatitis
7/22/2019 8:04:20 AM DURECT, Gilead Enter License Agreement For Long-Acting Injectable HIV Investigational Product